NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr |
What is the latest Net Current Assets ratio of NATCO PHARMA ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹4,327 Cr |
Mar2024 | ₹3,051 Cr |
Mar2023 | ₹2,317 Cr |
Mar2022 | ₹1,776 Cr |
Mar2021 | ₹1,819 Cr |
How is Net Current Assets of NATCO PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹4,327 Cr | 41.82 | |
Mar2024 | ₹3,051 Cr | 31.65 | |
Mar2023 | ₹2,317 Cr | 30.45 | |
Mar2022 | ₹1,776 Cr | -2.36 | |
Mar2021 | ₹1,819 Cr | - |
Compare Net Current Assets of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,488.6 Cr | -1.2% | -11.3% | -44.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -1.2% |
-11.3% |
-44.1% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses